• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Current Drug Shortages S - Z

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov.  Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  [S – Z]

Secretin Synthetic Human (ChiRhoStim) Injection (Initial posting-6/15/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
ChiRhoClin
Customer service- 1-877-272-4888
16 mcg vial
(NDC  67066-005-01)
Unavailable

Qualifying a new manufacturing site.

 

 OtherRevised 3/21/2014

 

Selenium Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
American Regent/Luitpold
1-800-645-1706

40 mcg/mL elemental selenium
10 mL vial, package of 25 (NDC 00157-6510-25) 

Unavailable. Product on backorder and will be made available as it is released.Shortage per Manufacturer: Manufacturing delayDelay in shipping of the drug. Demand increase for the drug.Reverifed 4/7/2014

 

Sincalide (Kinevac) Injection (Initial Posting Date) - 6/21/2013

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Bracco Diagnostics Inc
Customer Service:
1-877-Bracco9 (1-877-272-2269)
5 mcg/vial powder, lyophilized for solution NDC: 0270-0556-15

Limited supply of Kinevac is available. There will be intermittent inventory depletion over the next several months.  New orders that are placed with Bracco will remain on back order and may be partially fulfilled based on available Kinevac market units

 OtherReverified
4/7/2014

 

Sodium Chloride 0.9% Injection Bags (Initial Posting-1/15/2014)

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Health-System Pharmacists:  http://www.ashp.org/DocLibrary/Policy/Conservation-Strategies-for-IV-Fluids.pdf

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Baxter Healthcare Corporation
Customer Service:
1-888-229-0001
150 mL (NDC: 00338-0049-01)

Unavailable

Anticipate production to resume in 2Q 2014.

Please see the Dear Valued Baxter Customer Letter (PDF) dated December 16, 2013 and Dear Valued Baxter Customer Letter (PDF) dated March 12, 2014 for additional information.

Demand increase for the drugRevised
3/17/2014 

250 mL

(NDC: 00338-0049-02)
Baxter has this product on allocation

250 mL, PVC/DEHP-free

(NDC: 00338-6304-02)
Baxter has this product on allocation

500 mL

(NDC: 00338-0049-03)
Baxter has this product on allocation

500 mL, PVC/DEHP-free

(NDC: 00338-6304-03)
Baxter has this product on allocation

1000 mL

(NDC: 00338-0049-04)
Baxter has this product on allocation

B. Braun Medical Inc.

1-800-227-2862
250 mL bag, PVC/DEHP-free (NDC: 00264-7800-20)Intermittent interruptions in supplyDear Customer Letter (PDF - 86KB)Demand increase for the drugReverified
4/17/2014
500 mL bag, PVC/DEHP-free (NDC: 00264-7800-10)Intermittent interruptions in supply
1000 mL bag, PVC/DEHP-free (NDC: 00264-7800-00)Intermittent interruptions in supply
Hospira Inc. Customer Service:
1-877-946-7747
150 mL flexible container (NDC: 0409-7983-61)

Next delivery April 2014.  Estimated recovery April 2014.

Shortage per manufacturer: Available

 

Sustained heavy demand.  Customer allocations set at 100% of historic usage. 
Demand increase for the drug/Other

Revised
4/13/2014

250 mL Vis-IV container, PVC/DEHP-free (NDC: 0409-7983-25)

Next delivery April 2014.  Estimated recovery April 2014.

250 mL flexible container (NDC: 0409-7983-02)

Available

250 mL flexible container, 2 port (NDC: 0409-7983-53)Available
250 mL ADD-Vantage flexible container (NDC: 0409-7101-02)Available
500 mL flexible container, 2 port (NDC: 0409-7983-55)Available
500 mL flexible container (NDC: 0409-7983-03)

Next delivery early April 2014.

Estimated Recovery 3Q 2014.
1000 mL flexible container (NDC: 0409-7983-09)

Next delivery April 2014.

Estimated recovery late June 2014.
Fresenius Medical Care North America
1-800-323-5188
1000ml NDC: 49230-300-10

Fresenius has this product on allocation

 Demand increase for the drug3/13/2014

Fresenius Kabi, USA, LLC
(formerly APP Pharmaceuticals, LLC)

1-888-386-1300
Sodium Chloride 0.9% Freeflex Injection Solution for Intravenous Infusion
(Australian label / English)
Importation began March 2014.  Limited quantities available through direct order.Fresenius Kabi USA, LLC in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Freeflex Injection Solution into the U.S. market to address this shortage.

Please see the Dear Healthcare Professional Letter (PDF - 646KB) for additional product and supply information. Also attached is the Package Insert (PDF - 66KB) for product information. All orders must be placed with Fresenius Kabi Customer Service Department by calling 1-888-386-1300.
 
Other

Reverified

4/8/2014

freeflex container sizes: 
50 mL (NDC 63323-623-50) 
100 mL (NDC 63323-623-00) 
500 mL (NDC 63323-623-59) 
1000 mL (NDC 63323-623-10) 
Sodium Chloride 0.9% Freeflex Injection Solution for Intravenous Infusion
(Scandinavian label)
 
Fresenius Kabi USA, LLC in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Freeflex Injection Solution into the U.S. market to address this shortage.

Please see the Dear Healthcare Professional Letter (PDF - 660KB) for additional product and supply information. Also attached is the Package Insert (PDF - 66KB) for product information. All orders must be placed with Fresenius Kabi Customer Service Department by calling 1-888-386-1300.
freeflex container sizes: 
50 mL (NDC 63323-623-57) 
100 mL (NDC 63323-623-09) 
500 mL (NDC 63323-623-51) 

 

Sodium Chloride 23.4%

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Fresenius Kabi, USA

(formerly APP Pharmaceuticals, LLC)

1-888-386-1300

30 mL vials (NDC 63323-0087-30)Currently backordered. Next release anticipated April 2014. Check wholesalers for inventory.

Shortage per Manufacturer:
Increased demand

 

Demand increase for the drug.

Revised
4/8/2014

 
100 mL vials (NDC 63323-0088-61)Currently backordered. Next release anticipated May 2014. Check wholesalers for inventory.
200 mL vials (NDC 63323-0088-63)Backordered. Next estimated release May 2014.
American Regent/Luitpold
1-800-645-1706
30 mL vials, package of 25 (NDC 00517-2930-25)Unavailable - No product available for release. No plan to manufacture.

Shortage per Manufacturer: American Regent/Luitpold has discontinued manufacturing Concentrated Sodium Chloride Injection 23.4%.

Discontinuation of the manufacture of the drug.

Reverified 4/7/2014

100 mL vials, package of 25 (NDC 00517-2900-25)
Hospira Inc. Customer Service:
1-877-946-7747
4 mEq/mL; 250 mL bottle (NDC 0409-1130-02) This presentation has been discontinued.

Shortage per Manufacturer:
Manufacturing delay

OtherReverified
4/13/2014
4 mEq/mL; 100 mL bottle (NDC 0409-1141-02)

Next delivery TBD.

Expected recovery TBD.

 

Sodium Phosphate Injection (Also See Phosphate Injection)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
American Regent/Luitpold 1-800-645-1706

 
3 mmol/mL, 5 mL vials (NDC 00517-3405-25)

Unavailable - No product available for release. No plan to manufacture.


 


 

American Regent is currently not releasing the 5 mL, 15 mL, or the 50 mL vials.

 

OtherReverified
4/7/2014 
3 mmol/ml, 15 ml vial (NDC 00517-3415-25)
3 mmol/mL, 50 mL via (NDC 00517-3450-25)
Hospira, Inc.
Customer Service:
1-877-946-7747
3 mmol/mL, 15 mL vial (NDC 00409-7391-72)

Next delivery 2Q 2014.

Expected recovery 2Q 2014.

Hospira temporarily interrupts the production of Sodium Phosphates Injection, USP for the remainder of the year.  This will allow the firm to resolve manufacturing issues with this product.  Hospira anticipates sodium phosphates injection will return to the market in early 2014.  Until that time, Hospira is increasing production of Potassium Phosphates Injection, USP.

 

Shortage per manufacturer: manufacturing delay

Other

Reverified
4/13/2014

 

Succinylcholine (Anectine, Quelicin) Injection - (Initial posting-8/17/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service
1-877-946-7747
20 mg/mL; 10 mL vial
NDC 0409-6629-02

Product recovered

Product readily available through wholesaler.

 

Dear Healthcare Professional Letter (PDF - 52KB)

 

Shortage per manufacturer: Available; manufacturing delay


 

OtherReverified 4/13/2014
100 mg/mL; 10 mL vial
NDC 0409-6970-10
 
Temporarily suspended due to priority of other NDC; Please check with your wholesaler for available inventory.
Sandoz Inc.
Customer Service:
1-800-525-8747
Anectine,
20 mg/mL, 10 mL vial (NDC 00781-3009-95
Product on short term backorder. 

Delay in shipping.

Reverified
4/7/2014

 

 Sufentanil Citrate (Sufenta) Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Akorn:
1-800-932-5676

50 mcg/mL, 1 mL ampoule, 10 pack

(NDC 17478-0050-01)
Readily Available Delay in shipping of the drugRevised 4/16/2014

50 mcg/mL, 2 mL ampoule, 10 pack

(NDC 17478-0050-02)

Readily Available
50mcg/ml, 5ml ampule, 10 pack (NDC 7478-0050-05)Backordered.  Due June 2014.

Hospira, Inc.
Customer Service:
1-877-946-7747

Sufentanil 50 mcg/mL

1 mL ampule (NDC 0409-3380-31)

 
Next delivery and estimated recovery TBD.

Please check with your wholesaler for all available inventory.

Shortage per Manufacturer:
Manufacturing delay/Available

Other

Reverified 4/13/2014

Sufentanil 50 mcg/mL

1 mL vial (NDC 0409-3382-21)

Next delivery and estimated recovery TBD.

Sufentanil 50 mcg/mL
2 mL ampule (NDC 0409-3380-32)

Available

Sufentanil 50 mcg/mL

2 mL vial (NDC 0409-3382-22)

Next delivery and estimated recovery TBD.

Sufentanil 50 mcg/mL

5 mL ampule
(NDC 0409-3380-35)

Next delivery April 2014.

Estimated recovery 2Q 2014.
 
Sufentanil 50 mcg/mL 5 mL vial (NDC 0409-3382-25)Next delivery and estimated recovery TBD.
West-Ward Pharmaceuticals Customer Service:
1-800-631-2174

50 mcg/mL, 1 mL ampule(NDC 0641-6110-10)

West-Ward has limited inventory for the 2 mL and 5 mL ampuls.

 

West-Ward has accelerated production on this product.

West-Ward is anticipating having additional product available in April 2014.

 

Product will be made available as it is released.

Demand increase for the drug.

Revised
3/30/2014

50 mcg/mL, 2 mL ampule

(NDC 0641-6111-10)

50 mcg/mL, 5 mL ampule

(NDC 0641-6112-10)

 

Telavancin (Vibativ) Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Theravance, Inc.
1-855-633-8479
PDS 750 mg
(NDC 52118-001-01)

Available

Theravance, Inc. has commenced shipments of VIBATIV (telavancin) into the U.S. wholesaler channel.

Additional information on ordering VIBATIV can be obtained by calling Theravance at:
 1-855-7-THRX-SALES
 (855-784-7972).
 

 Other

Reverified
4/8/2014

PDS 250 mg
(NDC 52118-002-01)
VIBATIV 250mg will be re-introduced in the future

 

Tesamorelin (Egrifta) Injection Kit (Initial posting-3/26/2014)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
EMD Serono, Inc
1-877-714-2947
2 mg/vial  (NDC 44087-2011-2)Unavailable starting the week of 2/24/2014, unknown duration

Shortage per Manufacturer: Manufacturing Delay

 Other

 

 

Thiotepa (Thioplex) for Injection 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Bedford Laboratories
Customer Service
1-800-562-4797

15 mg Inj VL 2 mL (NDC 5539-0030-10)

Unavailable

Shortage: Pending Manufacturing Change or Addition.  

Availability of products are updated on the Bedford Laboratories website.

Other

Reverified
4/7/2014

Adienne
Guglielmo Bianchi, Customer Service
Tel: + 41.789.451.694
Fax: + 41.919.211.978

E-mail: guglielmo.bianchi@adienne.ch

15 mg vial

Please see the Dear Healthcare Professional Letter (PDF - 56KB) for information about emergency supplies that are now available to help address the shortage.

Adverse Event Reporting Instructions (Urgent Thiotepa Update (PDF - 176KB)

Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. OtherReverified 4/10/2014
100 mg vial

  

Tiopronin (Thiola) (Initial posting date 10/31/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Mission Pharmacal Company
1-800-292-7364 

100mg tablets
(NDC 0178-0900-01)
The product is currently available but the quantities are limited. The current supply is expected to run out in March 2014. The shortage duration is expected to be resolved by June 2014. Shortage per Manufacturer: API discontinuance Shortage of an active ingredientRevised 3/12/2014

 

Tobramycin Solution for Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Teva Pharmaceuticals
1-800-545-8800

40 mg/mL, 2 mL vial (NDC 00703-9402-04)

All tobramycin 40 mg/mL solution for injection are on long term back order.  Estimated release date 2Q 2015.
 

Shortage per manufacturer: Method remediation delays.  

Reverified
3/26/2014

40 mg/mL, 30 mL vial (NDC 00703-9416-01)

Mylan Institutional

 

1-888-258-4199 

40 mg/mL, 2 mL vial (NDC 0069-0088-02)

Available. 

 

Increased demand.

Revised

4/1/2014

40 mg/mL, 30 mL vial (NDC 67457-428-30)

Available.
 

40 mg/mL
30 mL vial
Novaplus 10's (NDC 0069-0302-02)
 

Available 

Fresenius Kabi, USA

(formerly APP Pharmaceuticals, LLC)

1-888-386-1300

10 mg/ml; 2ml vial (NDC 63323-0305-02)

Available
Check wholesaler inventory.
 

Shortage per Manufacturer:
Increase in demand/manufacturing delays

 

Available

Demand increase for the drug.

Revised 4/8/2014
 

40 mg/mL, 2 mL vial (NDC 63323-0306-02)

Available
Check wholesaler inventory.
 

40 mg/mL, 30 mL vial (NDC 63323-0306-30)

Available. Check wholesalers for inventory.

40 mg/mL, 50 mL vial (NDC 63323-0307-51)

Available. Check wholesalers for inventory.

40 mg/mL, 2 mL  Novaplus vial (NDC 63323-0306-55)

Backordered. 
No estimated delivery at this time.

40 mg/mL, 30 mL Novaplus vial (NDC 63323-0306-56)
 

Backordered.  No estimated delivery at this time.

1.2 gram 50 mL vial, preservative-free, 6 count (NDC 63323-0303-51)

Available.  Check wholesalers for inventory.

1.2 gram 50 mL Novaplus vial, preservative-free, 6 count (NDC 63323-0303-55)

Available.  Check wholesalers for inventory.

Hospira, Inc.
Customer Service
1-877-946-7747

80 mg/mL in 0.9% NaCl; 100 mL (NDC 0409-3470-23)

Next delivery and estimated recovery TBD

Please check with your wholesaler for available inventory.

 

Shortage per manufacturer: Manufacturing Delay.

 

 

Other

Revised
4/13/2014 

10 mg/mL; 2 mL vial
(NDC 0409-3577-01)

Next delivery 3Q 2014. Estimated recovery: 3Q 2014. 

40 mg/mL; 2 mL vial
(NDC 0409-3578-01)

Next delivery 3Q 2014. Estimated recovery: 3Q 2014. 

40 mg/mL; 50 mL vial
(NDC 0409-3590-02)

Next delivery and 

estimated 

recovery: TBD. 

 


Trace Elements
(initial posting date - 1/24/2013)

** A.S.P.E.N. - recently released new Parenteral Nutrition Trace Element Shortage Considerations.

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
American Regent/Luitpold
1-800-645-1706
Multitrace-4 Neonatal, 2 mL vial (NDC 00517-6202-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

American Regent is currently not releasing any other codes. 

 

Shortage per Manufacturer: Manufacturing delay

 

American Regent is currently releasing the MTE-5 Conc. 1 mL vials for code 00517-8201-25

 

 

 

Delay in shipping of the drug.  Demand increase for the drug.  

Revised
4/7/2014

Multitrace-4 Regular, 10 mL vial (NDC 00517-7410-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-4 Pediatric, 3 mL vial (NDC 00517-9203-25)
 

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-5 Regular, 10 mL vial (NDC 00517-8510-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-5 Concentrate 10 mL vial (NDC 00517-8210-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-4 Concentrate, 1 mL vial (NDC 00517-7201-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-4 Concentrate, 10 mL vial (NDC 00517-7210-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Multitrace-5 Concentrate 1 mL vial (NDC 00517-8201-25)

Available

Trace elements-4 pediatric injection, 10 mL vial (NDC 00517-9310-25)

All codes are unavailable - Product on backorder and will be made available as it is released.

Fresenius Kabi, USA

(formerly APP Pharmaceuticals, LLC)

1-888-386-1300

Addamel N injection, 10 mL ampule
(NDC 63323-143-97)
Importation began May 2013 and will continue until all patient needs are met with US product.  Ample available direct and through wholesalers.  Clinicians can order the product at pre-shortage levels.  Please check wholesalers for inventory and reference Addamel N.

Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Addamel N (adult trace elements) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 444KB) for additional product and supply information.  FK USA is releasing Addamel N to its authorized distributors.
 

Shortage per Manufacturer:
Increase in demand

Other Reverified
4/10/2014
Peditrace injection, 10 mL vial
(NDC 63323-147-10 )
Importation began May 2013 and will continue until all patient needs are met with US product.  Ample product available direct and through wholesalers.  Clinicians can order the product at pre-shortage levels.  Please check wholesalers for inventory.

Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Peditrace (pediatric trace elements) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 377KB) for additional product and supply information.  FK USA is releasing Peditrace to its authorized distributors.
 

Shortage per Manufacturer:
Increase in demand

OtherReverified 4/8/2014


 

 
Verapamil Hydrochloride Injection, USP
(Initial Posting Date - 4/17/2013)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747
2.5 mg/mL; 2 mL vial
(NDC 0409-1144-05)

Available

Shortage per Manufacturer: Manufacturing delay/Available

Other

Revised
4/13/2014 

2.5 mg/mL; 4 mL vial
(NDC 0409-1144-02)

Next delivery April 2014.  Estimated recovery: 2Q 2014.

2.5 mg/mL; 2 mL amp
(NDC 0409-4011-01)

Next delivery April 2014.

Estimated recovery: 2Q 2014.

2.5 mg/mL; 4 mL Anyr syringe

(NDC 0409-9633-05)

Available

 

Vitamin A Palmitate (Aquasol A)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc.
1-877-946-7747
50,000 units/mL, 2 mL ampule (NDC 61703-418-07)Next delivery TBDShortage per Manufacturer: Change in manufacturing siteOtherReverified 4/13/2014

 

Zinc Injection (Initial Posting Date - 2/15/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

American Regent/Luitpold
1-800-645-1706

Zinc Sulfate 1 mg/mL, 10 mL vial, package of 25 (NDC 00517-6110-25)

Unavailable - No product available for release.  No plan to manufacture.

American Regent is currently not releasing the 10 mL vial sizes.

OtherReverified
4/7/2014

Zinc Sulfate 5 mg/mL Concentrate, 5 mL vial, package of 25 (NDC 00517-8105-25) 

AvailableAmerican Regent is currently releasing the 5 mL vials (code 00517-8105-25)

Hospira, Inc.
Customer Service:
1-877-946-7747

Zinc Chloride 1 mg/mL, 10 mL vial
(NDC 0409-4090-01)

Available

Please check with your wholesaler for all available inventory.

 

Shortage per Manufacturer:
Available

OtherReverified
4/13/2014

Laboratoire Aguettant (Baxter Healthcare, U.S. distributor)

Baxter’s Center for Service
Tel: 1-888-229-0001

Zinc Injectable (zinc gluconate trihydrate) solution for infusion
1 mg/mL; 10 mL glass vial; 10 vials/box (NDC 60710-2320-1)

Available

Laboratoire Aguettant, and its authorized distributor, Baxter Healthcare, in conjunction with the FDA, are initiating a temporary importation of a Zinc Injectable (zinc gluconate trihydrate) solution for infusion into the United States market to address this shortage.

 

Please see the Dear Heathcare Professional Letter (PDF - 12MB)
for information about supplies that are now available to help address the shortage. All orders must be made directly with Baxter's Center for Service by calling 1-888-229-0001, or email: CFS_Customer_Service@baxter.com.

OtherReverified
4/10/2014

back to top of page

Current Drug Shortages Index